JLE

Epileptic Disorders

MENU

Post-encephalitic epilepsy in childhood: results from a prospective cohort study Volume 23, numéro 1, February 2021

  • [1] Kennedy P.G. Viral encephalitis: causes, differential diagnosis, and management. J Neurol Neurosurg Psychiatry. 2004;75:i10-i15. 1
  • [2] Wickström R., Fowler Å., Bogdanovic G., Bennet R., Eriksson M. Review of the aetiology, diagnostics and outcomes of childhood encephalitis from 1970 to 2009. Acta Paediatr. 2017;106:463-469. 3
  • [3] DuBray K., Anglemyer A., LaBeaud A.D. Epidemiology, outcomes and predictors of recovery in childhood encephalitis: a hospital-based study. The Pediatr Infect Dis J. 2013;32:839-844. 8
  • [4] Fowler Å., Stödberg T., Eriksson M., Wickström R. Long-term outcomes of acute encephalitis in childhood. Pediatrics. 2010;126:e828-e835. 4
  • [5] Rismanchi N., Gold J.J., Sattar S., Glaser C., Sheriff H., Proudfoot J. Epilepsy after resolution of presumed childhood encephalitis. Pediatr Neurol. 2015;53:65-72. 1
  • [6] Misra U.K., Kalita J. Seizures in encephalitis: predictors and outcome. Seizure. 2009;18:583-587. 8
  • [7] Liu X., Yan B., Wang R., Li C., Chen C., Zhou D. Seizure outcomes in patients with anti-NMDAR encephalitis: a follow-up study. Epilepsia. 2017;58:2104-2111. 12
  • [8] Thakur K.T., Motta M., Asemota A.O., Kirsch H.L., Benavides D., Schneider E. Predictors of outcome in acute encephalitis. Neurology. 2013;81:793-800. 9
  • [9] Annegers J.F., HauserWA, Beghi E., Nicolosi A., Kurland L.T. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38:1407-1410. 9
  • [10] Misra U.K., Tan C.T., Kalita J. Seizures in encephalitis. Neurol Asia. 2008;13:1-3. 1
  • [11] Singh T.D., Fugate J.E., Hocker S.E., Rabinstein A.A. Postencephalitic epilepsy: clinical characteristics and predictors. Epilepsia. 2015;56:133-138. 1
  • [12] Pillai S.C., Mohammad S.S., Hacohen Y., Tantsis E., Prelog K., Barnes E. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: clinical and etiologic risk factors. Epilepsia. 2016;57:e7-11. 1
  • [13] Yuan F., Jia R., Gao Q., Yang F., Yang X., Jiang Y. Early predictors of drug-resistant epilepsy development after convulsive status epilepticus. Eur Neurol. 2018;79:325-332.
  • [14] Sankar R. Initial treatment of epilepsy with antiepileptic drugs: pediatric issues. Neurology. 2004;63:S30-S39. 10
  • [15] Vining E.P., Mellitis E.D., Dorsen M.M., Cataldo M.F., Quaskey S.A., Spielberg S.P. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics. 1987;80:165-174. 2
  • [16] Zou X., Hong Z., Chen J., Zhou D. Is antiepileptic drug withdrawal status related to quality of life in seizure-free adult patients with epilepsy? Epilepsy Behav. 2014;31:129-135.
  • [17] Fisher R.S., Acevedo C., Arzimanoglou A., Bogacz A., Cross J.H., Elger C.E. ILAE Official Report: A Practical Clinical Definition of Epilepsy. Epilepsia. 2014;55:475-482. 4
  • [18] Hesdorffer D.C., Benn E.K., Cascino G.D., Hauser W.A. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009;50:1102-1108. 5
  • [19] Chen Y.J., Fang P.C., Chow J.C. Clinical characteristics and prognostic factors of postencephalitic epilepsy in children. J Child Neurol. 2006;21:1047-1051. 12
  • [20] Lee W.T., Yu T.W., Chang W.C., Shau W.Y. Risk factors for postencephalitic epilepsy in children: a hospital-based study in Taiwan. Eur J Paediatr Neurol. 2007;11:302-309. 5
  • [21] Rossor T., Benetou C., Wright S., Duignan S., Lascelles K., Robinson R. Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis. Mult Scler. 2020;26:333-342. 3
  • [22] Elbers J.M., Bitnun A., Richardson S.E., Ford-Jones E.L., Tellier R., Wald R. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics. 2007;119:e399-407. 2
  • [23] De Bruijn M.A., van Sonderen A., van Coevorden-Hameete M.H., Bastiaansen A.E., Schreurs M.W., Rouhl R.P. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis. Neurology. 2019;92:e2185-e2196. 19
  • [24] Titulaer M.J., McCracken L., Gabilondo I., Armangué T., Glaser C., Iizuka T. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157-165. 2
  • [25] Ercoli T., Defazio G., Muroni A. Status epilepticus in Hashimoto's encephalopathy. Seizure. 2019;70:1-5.